Literature DB >> 11815641

Gamma-glutamyltransferase and risk of stroke: the EUROSTROKE project.

M L Bots1, J T Salonen, P C Elwood, Y Nikitin, A Freire de Concalves, D Inzitari, J Sivenius, A Trichopoulou, J Tuomilehto, P J Koudstaal, D E Grobbee.   

Abstract

BACKGROUND: Alcohol consumption has been implicated in the aetiology of stroke. As data on alcohol consumption obtained by questionnaire are susceptible to misclassification, this study evaluated the association between gamma-glutamyltransferase (gamma-GT), as a marker for alcohol consumption, and fatal, non-fatal, haemorrhagic and ischaemic stroke in three European cohort studies, participating in EUROSTROKE.
METHODS: EUROSTROKE is a collaborative project among ongoing European cohort studies on incidence and risk factors of stroke. EUROSTROKE is designed as a nested case-control study. For each stroke case, two controls were sampled. Strokes were classified according to MONICA criteria or reviewed by a panel of four neurologists. At present, data on stroke and gamma-GT were available from cohorts in Cardiff (57 cases), Kuopio (66 cases), and Rotterdam (108 cases).
RESULTS: An increase in gamma-GT of one standard deviation (28.7 IU/ml) was associated with an age and sex adjusted 26% (95% CI 5 to 53) increase in risk of stroke. Adjustment for confounding variables such as drug use, history of myocardial infarction, total cholesterol, and diabetes mellitus did not materially attenuate the association. The risk of haemorrhagic stroke increased linearly with increase in gamma-GT. The association for cerebral infarction was not graded: the risk increased beyond the first quartile, and remained increased. The association of gamma-GT with stroke was significantly stronger among subjects without diabetes mellitus compared with subjects with diabetes mellitus (no association observed).
CONCLUSION: This EUROSTROKE analysis showed that an increased gamma-GT, as a marker of alcohol consumption, is associated with increased risk of stroke, in particular haemorrhagic stroke.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815641      PMCID: PMC1765511          DOI: 10.1136/jech.56.suppl_1.i25

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  17 in total

1.  Methodology of the modular ECG analysis system MEANS.

Authors:  J H van Bemmel; J A Kors; G van Herpen
Journal:  Methods Inf Med       Date:  1990-09       Impact factor: 2.176

2.  HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men.

Authors:  J T Salonen; R Salonen; K Seppänen; R Rauramaa; J Tuomilehto
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

Review 3.  Moderate alcohol consumption and stroke. The epidemiologic evidence.

Authors:  C A Camargo
Journal:  Stroke       Date:  1989-12       Impact factor: 7.914

4.  Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study.

Authors:  M L Bots; A W Hoes; P J Koudstaal; A Hofman; D E Grobbee
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

5.  Classification and natural history of clinically identifiable subtypes of cerebral infarction.

Authors:  J Bamford; P Sandercock; M Dennis; J Burn; C Warlow
Journal:  Lancet       Date:  1991-06-22       Impact factor: 79.321

6.  The FINMONICA Stroke Register. Community-based stroke registration and analysis of stroke incidence in Finland, 1983-1985.

Authors:  J Tuomilehto; C Sarti; E V Narva; K Salmi; J Sivenius; E Kaarsalo; V Salomaa; J Torppa
Journal:  Am J Epidemiol       Date:  1992-06-01       Impact factor: 4.897

7.  The value of laboratory tests for the screening and recognition of alcohol abuse in primary care patients.

Authors:  H L Hoeksema; G H de Bock
Journal:  J Fam Pract       Date:  1993-09       Impact factor: 0.493

8.  Is serum gamma-glutamyl transferase a good marker of alcohol intake in stroke patients?

Authors:  K Peck; R Shinton; G Beevers
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

9.  The diagnostic performance of computer programs for the interpretation of electrocardiograms.

Authors:  J L Willems; C Abreu-Lima; P Arnaud; J H van Bemmel; C Brohet; R Degani; B Denis; J Gehring; I Graham; G van Herpen
Journal:  N Engl J Med       Date:  1991-12-19       Impact factor: 91.245

10.  Determinants of disease and disability in the elderly: the Rotterdam Elderly Study.

Authors:  A Hofman; D E Grobbee; P T de Jong; F A van den Ouweland
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

View more
  17 in total

Review 1.  Alcoholic foamy degeneration and a markedly elevated GGT: a case report and literature review.

Authors:  Sanjeev Suri; Frank A Mitros; Jatinder P Ahluwalia
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

Review 2.  Gamma-glutamyl transferase and cardiovascular disease.

Authors:  Gjin Ndrepepa; Adnan Kastrati
Journal:  Ann Transl Med       Date:  2016-12

3.  γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery.

Authors:  Maria Franzini; Veronica Musetti; Daniela Guarino; Laura Caponi; Aldo Paolicchi; Michele Emdin; Ele Ferrannini; Monica Nannipieri
Journal:  Obes Surg       Date:  2018-05       Impact factor: 4.129

Review 4.  Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management.

Authors:  Alexandra Jichitu; Simona Bungau; Ana Maria Alexandra Stanescu; Cosmin Mihai Vesa; Mirela Marioara Toma; Cristiana Bustea; Stela Iurciuc; Marius Rus; Nicolae Bacalbasa; Camelia Cristina Diaconu
Journal:  Diagnostics (Basel)       Date:  2021-04-12

5.  4-Hydroxynonenal increases gamma-glutamyl transpeptidase gene expression through mitogen-activated protein kinase pathways.

Authors:  Hongqiao Zhang; Dale A Dickinson; Rui-Ming Liu; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2005-02-15       Impact factor: 7.376

6.  Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults.

Authors:  Alexander M Strasak; Cecily C Kelleher; Jochen Klenk; Larry J Brant; Elfriede Ruttmann; Kilian Rapp; Hans Concin; Günter Diem; Karl P Pfeiffer; Hanno Ulmer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-10       Impact factor: 8.311

Review 7.  Redox regulation of gamma-glutamyl transpeptidase.

Authors:  Hongqiao Zhang; Henry Jay Forman
Journal:  Am J Respir Cell Mol Biol       Date:  2009-08-14       Impact factor: 6.914

8.  Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey.

Authors:  Duk-Hee Lee; Brian Buijsse; Lyn Steffen; Jordan Holtzman; Russell Luepker; David R Jacobs
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2009-02

9.  Which biomarkers are predictive specifically for cardiovascular or for non-cardiovascular mortality in men? Evidence from the Caerphilly Prospective Study (CaPS).

Authors:  Christopher C Patterson; Stefan Blankenberg; Yoav Ben-Shlomo; Luke Heslop; Antony Bayer; Gordon Lowe; Tanja Zeller; John Gallacher; Ian Young; John Yarnell
Journal:  Int J Cardiol       Date:  2015-08-05       Impact factor: 4.164

10.  Increased concentration of serum gamma-glutamyl transferase in ischemic stroke patients.

Authors:  Teja Ram Kalirawna; Jitendra Rohilla; Shyam Sunder Bairwa; Sunil Kumar Gothwal; Pinki Tak; Rajesh Jain
Journal:  Brain Circ       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.